Meet the Roquette Health & Pharma Solutions Team
Roquette is pleased to announce that we will be present at DDF Summit 2025! From June 2 to 4, join the Roquette Health & Pharma Solutions Team to meet our experts and discover our latest innovations!
Don’t miss our expert presentation.
Steve Amoussou-Guenou, Technical Developer Manager Europe at Roquette, will give a presentation about advancing inhalation therapies.
Title: Advancing Inhalation Therapies: The Role of Integrated Inhalation Solutions in Optimizing Drug Delivery to the Lung
Inhalation therapies are gaining momentum, offering rapid onset and targeted delivery for various conditions. This session presents Roquette’s integrated inhalation platform, combining PEARLITOL® 200 INH mannitol and specialized inhalation capsules, to address key challenges in dry powder inhaler (DPI) development. Learn how this approach streamlines formulation design, supports regulatory compliance, and accelerates development timelines for innovative and generic inhaled therapies.
Time and Location
Tuesday, June 3 – 12:30 -13:00 (12.30 p.m. - 1:00 p.m.)
Room 1
Explore our extensive portfolio of pharmaceutical products and solutions firsthand with our live samples. Our offerings are designed to meet the dynamic needs of the pharma industry.
Visit our booth to engage with our experts, discuss our comprehensive solutions, and access detailed documentation. We're excited to present some of our latest innovations, including the following:
- PEARLITOL® 200 INH mannitol is designed to support consistent and reliable performance in dry powder inhalers (DPIs), with specific particle size distribution. It is compatible with a wide range of APIs, non-hygroscopic and humidity-stable with lung tolerability, and an efficient API carrier with high solubility contributing to uniform drug delivery.
- KLEPTOSE® F 7% beta-cyclodextrin is an innovative beta-cyclodextrin grade designed to optimize tablet formulation performance. Engineered to support OTC and pharma formulators’ product needs, KLEPTOSE® F 7% delivers a combination of consistent particle size distribution and low moisture content (4-7%). It is ideal for chewable, suckable and effervescent tablets, offering both enhanced product stability, taste masking and excellent tableting properties.
- Coatings Platform: Our wide portfolio offers high-quality film coating systems and sugar-free sugar coating alternatives for oral solid forms for pharmaceutical and nutraceutical applications.
- ReadiLYCOAT® plant-based ready-to-use coating systems: A plant-based polymer as a base for a wide range of high-quality film coatings and sugar-free sugar coating for immediate release for pharma, with a wide range of colors.
- Tabshield® ready-to-use film coating systems: A large range of high-quality film coating systems for immediate release (HPMC- and PVA-based) for pharma and nutra applications and enteric release (methacrylic acid-based) for pharma, with a wide range of colors, and a gloss topcoat system.
About DDF Summit
Since the first summit in 2009, the summit has grown in size and scope to accommodate the expanding audience and to align with ongoing industry developments and new challenges. With over 400 attendees in 2023 and even more expected in 2024, the summit attracts senior pharmaceutical leaders. Our expansive agenda is built around four key content streams, aiming to encompass all of the main industry areas.
About Roquette Health & Pharma Solutions
Roquette Health & Pharma Solutions aims to create a better and healthier future for generations to come by partnering with customers to solve the toughest challenges in drug delivery. Our mission is to support the development of life-saving treatments worldwide by providing safe ingredients and raw materials for the pharmaceutical, nutraceutical and biopharmaceutical industries.
About the speaker
Steve Amoussou-Guenou is Technical Developer Manager Europe with Roquette Health & Pharma Solutions. In this role, he leads a team looking after all aspects of technical support for Roquette European pharma customers, including the use of Roquette excipients for their pharmaceutical development projects, offering technical guidance in formulation/process development, quality and regulatory affairs, and the development of innovative solutions.
Steve Amoussou-Guenou has more than 15 years of experience in the pharmaceutical industry. Before joining Roquette, he worked for a variety of organizations, including big pharma, research institutes, and CDMOs. He is a qualified industrial pharmacist and holds a Master of Science degree.
